Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 04/30/24
End: 09/30/24
Due: 09/30/25
Phase: N/A
Priority: Normal
Start: 07/23/23
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 03/31/24
End: 08/31/24
Due: 08/31/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions | NCT06273254 | Viatris Inc. | user2@example.com | None | 2024-04-30 | 2024-09-30 | 2025-09-30 | - | - | 2025-07-14 |
| Safety and Efficacy Evaluation of <Dovprela Tablets 200 mg> by Post-marketing Surveillance | NCT06471088 | Viatris Inc. | user2@example.com | None | 2023-07-23 | 2026-06-30 | 2027-06-30 | - | - | 2025-07-14 |
| A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions | NCT06266988 | Viatris Inc. | user2@example.com | None | 2024-03-31 | 2024-08-31 | 2025-08-31 | - | - | 2025-07-14 |